Загрузка...
Rituximab for the treatment of IgG4-related orbital disease: experience from five cases
PURPOSE: To review the clinical efficacy and safety of rituximab for treatment of IgG4-related orbital disease (IgG4-ROD). DESIGN: Retrospective multicentre interventional case series. METHODS: Chart review for five cases of biopsy-confirmed IgG4-ROD (IgG4+>10/HPF, ratio of IgG4+/IgG+>40%) tre...
Сохранить в:
| Опубликовано в: : | Eye (Lond) |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4289839/ https://ncbi.nlm.nih.gov/pubmed/25341435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2014.251 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|